Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03850795
Title HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Terminated
Gender male
Phase Phase III
Variant Requirements No
Sponsors Hinova Pharmaceuticals USA, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | NLD | ITA | GBR | FRA | FIN | ESP | DNK | DEU | CAN | AUT | AUS


No variant requirements are available.